July 31, 2015 · STOCK Act disclosure
Representative James B. Renacci (Republican-OH) bought Alnylam Pharmaceuticals, Inc., a stock transaction, valued at $15,001 - $50,000. The trade took place on July 31, 2015 and was disclosed on August 11, 2015 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.